Trial Profile
Clinical Trials Insight: 700026203
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2007
Price :
$35
*
At a glance
- Drugs LE SN38 (Primary)
- Indications Triple negative breast cancer
- Focus Therapeutic Use
- Sponsors NeoPharm Inc
- 20 Aug 2007 New trial record.